Shopping Cart
- Remove All
- Your shopping cart is currently empty
(S)-VQW-765 ((S)-AQW-051) is an orally active, selective, and effective partial agonist of the α7 nicotinic acetylcholine receptor (nAChR), with potential applications in treating cognitive disorders related to neurological diseases, including Alzheimer's disease and schizophrenia.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | Inquiry | 6-8 weeks | |
50 mg | Inquiry | 6-8 weeks | |
100 mg | Inquiry | 6-8 weeks |
Description | (S)-VQW-765 ((S)-AQW-051) is an orally active, selective, and effective partial agonist of the α7 nicotinic acetylcholine receptor (nAChR), with potential applications in treating cognitive disorders related to neurological diseases, including Alzheimer's disease and schizophrenia. |
Alias | (S)-AQW-051 |
Molecular Weight | 294.39 |
Formula | C19H22N2O |
Storage | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.